Stiefel Calls Out Perrigo For Generic Rogaine Plan

Law360, New York (October 13, 2009, 7:41 PM EDT) -- Stiefel Research Australia Pty Ltd., a subsidiary of skin care pharmaceutical company Stiefel Laboratories, has sued health care supplier Perrigo Co. and an Israeli subsidiary, alleging Perrigo's abbreviated new drug application for a generic male hair care product infringes Stiefel's patent governing the composition of Men's Rogaine.

Lodged in the U.S. District Court for the District of Delaware Tuesday, Stiefel's complaint seeks a judgment that Perrigo's plan infringes its intellectual property and a permanent injunction barring the company from making, importing or selling products with the...
To view the full article, register now.